Pre-exposure prophylaxis to prevent the acquisition of HIV-1 infection (PROUD): effectiveness results from the pilot phase of a pragmatic open-label randomised trial

Public Health England. HIV in the United Kingdom: 2014 Report. London, 2014. Nakagawa, 2015, Projected lifetime healthcare costs associated with HIV infection, PLoS One, 10, e0125018, 10.1371/journal.pone.0125018 Phillips, 2013, Increased HIV incidence in men who have sex with men despite high levels of ART-induced viral suppression: analysis of an extensively documented epidemic, PLoS One, 8, e55312, 10.1371/journal.pone.0055312 Wilson, 2012, HIV treatment as prevention: natural experiments highlight limits of antiretroviral treatment as HIV prevention, PLoS Med, 9, e1001231, 10.1371/journal.pmed.1001231 Brown, 2014, WHO ‘Treatment as Prevention’ guidelines are unlikely to decrease HIV transmission in the UK unless undiagnosed HIV infections are reduced, AIDS, 28, 281, 10.1097/QAD.0000000000000137 Grant, 2010, Preexposure chemoprophylaxis for HIV prevention in men who have sex with men, N Engl J Med, 363, 2587, 10.1056/NEJMoa1011205 Baeten, 2012, Antiretroviral prophylaxis for HIV prevention in heterosexual men and women, N Engl J Med, 367, 399, 10.1056/NEJMoa1108524 Thigpen, 2012, Antiretroviral preexposure prophylaxis for heterosexual HIV transmission in Botswana, N Engl J Med, 367, 423, 10.1056/NEJMoa1110711 Choopanya, 2013, Antiretroviral prophylaxis for HIV infection in injecting drug users in Bangkok, Thailand (the Bangkok Tenofovir Study): a randomised, double-blind, placebo-controlled phase 3 trial, Lancet, 381, 2083, 10.1016/S0140-6736(13)61127-7 Cassell, 2006, Risk compensation: the Achilles' heel of innovations in HIV prevention?, BMJ, 332, 605, 10.1136/bmj.332.7541.605 Underhill, 2011, Preexposure chemoprophylaxis for HIV prevention, N Engl J Med, 364, 1374 McCormack, 2012, The British HIV Association/British Association for Sexual Health and HIV Position Statement on pre-exposure prophylaxis in the UK, Int J STD AIDS, 23, 1, 10.1258/ijsa.2011.051211 European Medicines Agency. Reflection paper on the non-clinical and clinical development for oral and topical HIV pre-exposure prophylaxis (PrEP). EMA/171264/2012. London, 2012. European Centre for Disease Prevention and Control. Evaluating HIV treatment as prevention in the European context. Solna, 2012. Standards Unit, Microbiology Services, Public Health England. UK Standards for Microbiology Investigations. Sexually Transmitted Infections. London, 2013. Anderson, 2012, Emtricitabine-tenofovir concentrations and pre-exposure prophylaxis efficacy in men who have sex with men, Sci Transl Med, 4, 151ra25, 10.1126/scitranslmed.3004006 Browne, 2012, Interpreting and investigating proteinuria, BMJ, 344, e2339, 10.1136/bmj.e2339 Asboe, 2012, British HIV Association guidelines for the routine investigation and monitoring of adult HIV-1-infected individuals 2011, HIV Med, 13, 1, 10.1111/j.1468-1293.2011.00971.x Sterne, 2001, Sifting the evidence-what's wrong with significance tests?, BMJ, 322, 226, 10.1136/bmj.322.7280.226 Buchbinder, 2014, HIV pre-exposure prophylaxis in men who have sex with men and transgender women: a secondary analysis of a phase 3 randomised controlled efficacy trial, Lancet Infect Dis, 14, 468, 10.1016/S1473-3099(14)70025-8 Breslow, 1980 US Public Health Service. Preexposure prophylaxis for the prevention of HIV infection in the United States–2014: a clinical practice guideline. Atlanta, 2014. Van Damme, 2012, Preexposure prophylaxis for HIV infection among African women, N Engl J Med, 367, 411, 10.1056/NEJMoa1202614 Marrazzo, 2015, Tenofovir-based preexposure prophylaxis for HIV infection among African women, N Engl J Med, 372, 509, 10.1056/NEJMoa1402269 Aghaizu A, Murphy G, Tosswill J, et al. HIV incidence among people who attend sexual health clinics in England in 2012: estimates using a biomarker for recent infection. BASHH Spring Conference 2015; June 1–3, 2015; Glasgow, UK. Abstract O4. Antonucci S, Desai M, Dolling D, et al. The UK PROUD PrEP Pilot study: a baseline analysis. 20th International AIDS Conference; July 20–25, 2014; Melbourne, Australia. Abstract THPE197. van de Vijver, 2013, Preexposure prophylaxis will have a limited impact on HIV-1 drug resistance in sub-Saharan Africa: a comparison of mathematical models, AIDS, 27, 2943, 10.1097/01.aids.0000433237.63560.20 Cambiano V, Miners A, Dunn D, et al. Is pre-exposure prophylaxis for HIV prevention cost-effective in men who have sex with men who engage in condomless sex in the UK? BASHH Spring Conference 2015; June 1–3, 2015; Glasgow, UK. Abstract O1. Molina J-M, Capitant C, Charreau I, et al. On demand PrEP with oral TDF-FTC in MSM: results of the ANRS Ipergay trial. Conference on Retroviruses and Opportunistic Infections; Feb 23–26, 2015; Seattle, WA, USA. Abstract 23LB.